Role of RNA structures in c-myc and c-fos gene regulations. 1988

M Piechaczyk, and J M Blanchard, and A Bonnieu, and P Fort, and N Mechti, and J Rech, and M Cuny, and L Marty, and F Ferré, and B Lebleu
Laboratoire de Biologie Moléculaire, UA CNRS 1191, USTL, Montpellier, France.

Proto-oncogenes c-myc and c-fos are subjected to a complex set of controls operating both at the transcriptional and post-transcriptional levels. We report here that: (i) antisense transcription occurs at the murine c-myc locus. However, its biological significance remains to be established; (ii) transcription of both genes is regulated in various situations by a block to elongation of nascent RNA chains. In the case of c-myc, the blockade involves a RNA structure whose nature remains unknown; (iii) elements responsible for the high degree of instability of c-myc and c-fos mRNAs reside in their 3' non-coding regions. A U-rich region, reminiscent of that present in the granulocyte-monocyte colony-stimulating factor mRNA destabilizer, is likely to be involved in the rapid degradation of c-fos mRNA; (iv) exon 1 substitution by intron 1-derived sequences lessens or negates the effect of the 3' destabilizer in abnormal c-myc RNAs from Burkitt's lymphomas and mouse plasmacytomas.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011519 Proto-Oncogenes Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc. Proto-Oncogene,Proto Oncogene,Proto Oncogenes
D002645 Chickens Common name for the species Gallus gallus, the domestic fowl, in the family Phasianidae, order GALLIFORMES. It is descended from the red jungle fowl of SOUTHEAST ASIA. Gallus gallus,Gallus domesticus,Gallus gallus domesticus,Chicken
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012313 RNA A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) RNA, Non-Polyadenylated,Ribonucleic Acid,Gene Products, RNA,Non-Polyadenylated RNA,Acid, Ribonucleic,Non Polyadenylated RNA,RNA Gene Products,RNA, Non Polyadenylated
D012323 RNA Processing, Post-Transcriptional Post-transcriptional biological modification of messenger, transfer, or ribosomal RNAs or their precursors. It includes cleavage, methylation, thiolation, isopentenylation, pseudouridine formation, conformational changes, and association with ribosomal protein. Post-Transcriptional RNA Modification,RNA Processing,Post-Transcriptional RNA Processing,Posttranscriptional RNA Processing,RNA Processing, Post Transcriptional,RNA Processing, Posttranscriptional,Modification, Post-Transcriptional RNA,Modifications, Post-Transcriptional RNA,Post Transcriptional RNA Modification,Post Transcriptional RNA Processing,Post-Transcriptional RNA Modifications,Processing, Posttranscriptional RNA,Processing, RNA,RNA Modification, Post-Transcriptional,RNA Modifications, Post-Transcriptional
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

M Piechaczyk, and J M Blanchard, and A Bonnieu, and P Fort, and N Mechti, and J Rech, and M Cuny, and L Marty, and F Ferré, and B Lebleu
December 1989, Oncogene,
M Piechaczyk, and J M Blanchard, and A Bonnieu, and P Fort, and N Mechti, and J Rech, and M Cuny, and L Marty, and F Ferré, and B Lebleu
July 1994, The Journal of clinical endocrinology and metabolism,
M Piechaczyk, and J M Blanchard, and A Bonnieu, and P Fort, and N Mechti, and J Rech, and M Cuny, and L Marty, and F Ferré, and B Lebleu
May 1988, Genes & development,
M Piechaczyk, and J M Blanchard, and A Bonnieu, and P Fort, and N Mechti, and J Rech, and M Cuny, and L Marty, and F Ferré, and B Lebleu
January 1987, AIDS research and human retroviruses,
M Piechaczyk, and J M Blanchard, and A Bonnieu, and P Fort, and N Mechti, and J Rech, and M Cuny, and L Marty, and F Ferré, and B Lebleu
June 1986, The Journal of biological chemistry,
M Piechaczyk, and J M Blanchard, and A Bonnieu, and P Fort, and N Mechti, and J Rech, and M Cuny, and L Marty, and F Ferré, and B Lebleu
November 1988, Cell differentiation and development : the official journal of the International Society of Developmental Biologists,
M Piechaczyk, and J M Blanchard, and A Bonnieu, and P Fort, and N Mechti, and J Rech, and M Cuny, and L Marty, and F Ferré, and B Lebleu
November 1986, Experimental cell research,
M Piechaczyk, and J M Blanchard, and A Bonnieu, and P Fort, and N Mechti, and J Rech, and M Cuny, and L Marty, and F Ferré, and B Lebleu
January 1984, Nature,
M Piechaczyk, and J M Blanchard, and A Bonnieu, and P Fort, and N Mechti, and J Rech, and M Cuny, and L Marty, and F Ferré, and B Lebleu
November 2013, Der Pathologe,
M Piechaczyk, and J M Blanchard, and A Bonnieu, and P Fort, and N Mechti, and J Rech, and M Cuny, and L Marty, and F Ferré, and B Lebleu
February 2003, Chinese medical journal,
Copied contents to your clipboard!